Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market Growth 2025-2031
The global Proliferative Vitreoretinopathy (PVR) Therapeutics market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Proliferative Vitreoretinopathy (PVR) Therapeutics Industry Forecast” looks at past sales and reviews total world Proliferative Vitreoretinopathy (PVR) Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Proliferative Vitreoretinopathy (PVR) Therapeutics sales for 2025 through 2031. With Proliferative Vitreoretinopathy (PVR) Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Proliferative Vitreoretinopathy (PVR) Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Proliferative Vitreoretinopathy (PVR) Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Proliferative Vitreoretinopathy (PVR) Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Proliferative Vitreoretinopathy (PVR) Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Proliferative Vitreoretinopathy (PVR) Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Proliferative Vitreoretinopathy (PVR) Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Proliferative Vitreoretinopathy (PVR) Therapeutics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Proliferative Vitreoretinopathy (PVR) Therapeutics market?
What factors are driving Proliferative Vitreoretinopathy (PVR) Therapeutics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Proliferative Vitreoretinopathy (PVR) Therapeutics market opportunities vary by end market size?
How does Proliferative Vitreoretinopathy (PVR) Therapeutics break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Proliferative Vitreoretinopathy (PVR) Therapeutics Industry Forecast” looks at past sales and reviews total world Proliferative Vitreoretinopathy (PVR) Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Proliferative Vitreoretinopathy (PVR) Therapeutics sales for 2025 through 2031. With Proliferative Vitreoretinopathy (PVR) Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Proliferative Vitreoretinopathy (PVR) Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Proliferative Vitreoretinopathy (PVR) Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Proliferative Vitreoretinopathy (PVR) Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Proliferative Vitreoretinopathy (PVR) Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Proliferative Vitreoretinopathy (PVR) Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Proliferative Vitreoretinopathy (PVR) Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Proliferative Vitreoretinopathy (PVR) Therapeutics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- PRM-167
- XOMA-089
- Others
- Hospital
- Clinic
- ASCs
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis AG
- Promedior Inc
- RXi Pharmaceuticals Corp
What is the 10-year outlook for the global Proliferative Vitreoretinopathy (PVR) Therapeutics market?
What factors are driving Proliferative Vitreoretinopathy (PVR) Therapeutics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Proliferative Vitreoretinopathy (PVR) Therapeutics market opportunities vary by end market size?
How does Proliferative Vitreoretinopathy (PVR) Therapeutics break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Garment Rivets Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Garment Rivets by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Garment Rivets by Country/Region, 2020, 2024 & 2031
2.2 Garment Rivets Segment by Type
2.2.1 Fan Rivets
2.2.2 Blind Rivet
2.2.3 Tree Rivets
2.2.4 Others
2.3 Garment Rivets Sales by Type
2.3.1 Global Garment Rivets Sales Market Share by Type (2020-2025)
2.3.2 Global Garment Rivets Revenue and Market Share by Type (2020-2025)
2.3.3 Global Garment Rivets Sale Price by Type (2020-2025)
2.4 Garment Rivets Segment by Application
2.4.1 Commercial
2.4.2 Household
2.4.3 Others
2.5 Garment Rivets Sales by Application
2.5.1 Global Garment Rivets Sale Market Share by Application (2020-2025)
2.5.2 Global Garment Rivets Revenue and Market Share by Application (2020-2025)
2.5.3 Global Garment Rivets Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Garment Rivets Breakdown Data by Company
3.1.1 Global Garment Rivets Annual Sales by Company (2020-2025)
3.1.2 Global Garment Rivets Sales Market Share by Company (2020-2025)
3.2 Global Garment Rivets Annual Revenue by Company (2020-2025)
3.2.1 Global Garment Rivets Revenue by Company (2020-2025)
3.2.2 Global Garment Rivets Revenue Market Share by Company (2020-2025)
3.3 Global Garment Rivets Sale Price by Company
3.4 Key Manufacturers Garment Rivets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Garment Rivets Product Location Distribution
3.4.2 Players Garment Rivets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GARMENT RIVETS BY GEOGRAPHIC REGION
4.1 World Historic Garment Rivets Market Size by Geographic Region (2020-2025)
4.1.1 Global Garment Rivets Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Garment Rivets Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Garment Rivets Market Size by Country/Region (2020-2025)
4.2.1 Global Garment Rivets Annual Sales by Country/Region (2020-2025)
4.2.2 Global Garment Rivets Annual Revenue by Country/Region (2020-2025)
4.3 Americas Garment Rivets Sales Growth
4.4 APAC Garment Rivets Sales Growth
4.5 Europe Garment Rivets Sales Growth
4.6 Middle East & Africa Garment Rivets Sales Growth
5 AMERICAS
5.1 Americas Garment Rivets Sales by Country
5.1.1 Americas Garment Rivets Sales by Country (2020-2025)
5.1.2 Americas Garment Rivets Revenue by Country (2020-2025)
5.2 Americas Garment Rivets Sales by Type (2020-2025)
5.3 Americas Garment Rivets Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Garment Rivets Sales by Region
6.1.1 APAC Garment Rivets Sales by Region (2020-2025)
6.1.2 APAC Garment Rivets Revenue by Region (2020-2025)
6.2 APAC Garment Rivets Sales by Type (2020-2025)
6.3 APAC Garment Rivets Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Garment Rivets by Country
7.1.1 Europe Garment Rivets Sales by Country (2020-2025)
7.1.2 Europe Garment Rivets Revenue by Country (2020-2025)
7.2 Europe Garment Rivets Sales by Type (2020-2025)
7.3 Europe Garment Rivets Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Garment Rivets by Country
8.1.1 Middle East & Africa Garment Rivets Sales by Country (2020-2025)
8.1.2 Middle East & Africa Garment Rivets Revenue by Country (2020-2025)
8.2 Middle East & Africa Garment Rivets Sales by Type (2020-2025)
8.3 Middle East & Africa Garment Rivets Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Garment Rivets
10.3 Manufacturing Process Analysis of Garment Rivets
10.4 Industry Chain Structure of Garment Rivets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Garment Rivets Distributors
11.3 Garment Rivets Customer
12 WORLD FORECAST REVIEW FOR GARMENT RIVETS BY GEOGRAPHIC REGION
12.1 Global Garment Rivets Market Size Forecast by Region
12.1.1 Global Garment Rivets Forecast by Region (2026-2031)
12.1.2 Global Garment Rivets Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Garment Rivets Forecast by Type (2026-2031)
12.7 Global Garment Rivets Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Shun Shuay Enterprise
13.1.1 Shun Shuay Enterprise Company Information
13.1.2 Shun Shuay Enterprise Garment Rivets Product Portfolios and Specifications
13.1.3 Shun Shuay Enterprise Garment Rivets Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Shun Shuay Enterprise Main Business Overview
13.1.5 Shun Shuay Enterprise Latest Developments
13.2 Starling
13.2.1 Starling Company Information
13.2.2 Starling Garment Rivets Product Portfolios and Specifications
13.2.3 Starling Garment Rivets Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Starling Main Business Overview
13.2.5 Starling Latest Developments
13.3 Fitrite International
13.3.1 Fitrite International Company Information
13.3.2 Fitrite International Garment Rivets Product Portfolios and Specifications
13.3.3 Fitrite International Garment Rivets Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Fitrite International Main Business Overview
13.3.5 Fitrite International Latest Developments
13.4 Yiwu Xingmei Jewelry
13.4.1 Yiwu Xingmei Jewelry Company Information
13.4.2 Yiwu Xingmei Jewelry Garment Rivets Product Portfolios and Specifications
13.4.3 Yiwu Xingmei Jewelry Garment Rivets Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Yiwu Xingmei Jewelry Main Business Overview
13.4.5 Yiwu Xingmei Jewelry Latest Developments
13.5 Dongguan Yongfei Hardware Product
13.5.1 Dongguan Yongfei Hardware Product Company Information
13.5.2 Dongguan Yongfei Hardware Product Garment Rivets Product Portfolios and Specifications
13.5.3 Dongguan Yongfei Hardware Product Garment Rivets Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Dongguan Yongfei Hardware Product Main Business Overview
13.5.5 Dongguan Yongfei Hardware Product Latest Developments
13.6 Linyi Jinmei Metal Products
13.6.1 Linyi Jinmei Metal Products Company Information
13.6.2 Linyi Jinmei Metal Products Garment Rivets Product Portfolios and Specifications
13.6.3 Linyi Jinmei Metal Products Garment Rivets Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Linyi Jinmei Metal Products Main Business Overview
13.6.5 Linyi Jinmei Metal Products Latest Developments
13.7 Dongguan Jiacai Hardware
13.7.1 Dongguan Jiacai Hardware Company Information
13.7.2 Dongguan Jiacai Hardware Garment Rivets Product Portfolios and Specifications
13.7.3 Dongguan Jiacai Hardware Garment Rivets Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Dongguan Jiacai Hardware Main Business Overview
13.7.5 Dongguan Jiacai Hardware Latest Developments
13.8 Yiwu Oleeya Garment Accessories Factory
13.8.1 Yiwu Oleeya Garment Accessories Factory Company Information
13.8.2 Yiwu Oleeya Garment Accessories Factory Garment Rivets Product Portfolios and Specifications
13.8.3 Yiwu Oleeya Garment Accessories Factory Garment Rivets Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Yiwu Oleeya Garment Accessories Factory Main Business Overview
13.8.5 Yiwu Oleeya Garment Accessories Factory Latest Developments
13.9 Cixi Pat Fasteners
13.9.1 Cixi Pat Fasteners Company Information
13.9.2 Cixi Pat Fasteners Garment Rivets Product Portfolios and Specifications
13.9.3 Cixi Pat Fasteners Garment Rivets Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Cixi Pat Fasteners Main Business Overview
13.9.5 Cixi Pat Fasteners Latest Developments
13.10 Foshan Sailuk Rivet
13.10.1 Foshan Sailuk Rivet Company Information
13.10.2 Foshan Sailuk Rivet Garment Rivets Product Portfolios and Specifications
13.10.3 Foshan Sailuk Rivet Garment Rivets Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Foshan Sailuk Rivet Main Business Overview
13.10.5 Foshan Sailuk Rivet Latest Developments
13.11 Shenzhen Allcheers Electronic Technology
13.11.1 Shenzhen Allcheers Electronic Technology Company Information
13.11.2 Shenzhen Allcheers Electronic Technology Garment Rivets Product Portfolios and Specifications
13.11.3 Shenzhen Allcheers Electronic Technology Garment Rivets Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Shenzhen Allcheers Electronic Technology Main Business Overview
13.11.5 Shenzhen Allcheers Electronic Technology Latest Developments
13.12 Foshan Shunde Kamol Decorative Materials
13.12.1 Foshan Shunde Kamol Decorative Materials Company Information
13.12.2 Foshan Shunde Kamol Decorative Materials Garment Rivets Product Portfolios and Specifications
13.12.3 Foshan Shunde Kamol Decorative Materials Garment Rivets Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Foshan Shunde Kamol Decorative Materials Main Business Overview
13.12.5 Foshan Shunde Kamol Decorative Materials Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Garment Rivets Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Garment Rivets by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Garment Rivets by Country/Region, 2020, 2024 & 2031
2.2 Garment Rivets Segment by Type
2.2.1 Fan Rivets
2.2.2 Blind Rivet
2.2.3 Tree Rivets
2.2.4 Others
2.3 Garment Rivets Sales by Type
2.3.1 Global Garment Rivets Sales Market Share by Type (2020-2025)
2.3.2 Global Garment Rivets Revenue and Market Share by Type (2020-2025)
2.3.3 Global Garment Rivets Sale Price by Type (2020-2025)
2.4 Garment Rivets Segment by Application
2.4.1 Commercial
2.4.2 Household
2.4.3 Others
2.5 Garment Rivets Sales by Application
2.5.1 Global Garment Rivets Sale Market Share by Application (2020-2025)
2.5.2 Global Garment Rivets Revenue and Market Share by Application (2020-2025)
2.5.3 Global Garment Rivets Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Garment Rivets Breakdown Data by Company
3.1.1 Global Garment Rivets Annual Sales by Company (2020-2025)
3.1.2 Global Garment Rivets Sales Market Share by Company (2020-2025)
3.2 Global Garment Rivets Annual Revenue by Company (2020-2025)
3.2.1 Global Garment Rivets Revenue by Company (2020-2025)
3.2.2 Global Garment Rivets Revenue Market Share by Company (2020-2025)
3.3 Global Garment Rivets Sale Price by Company
3.4 Key Manufacturers Garment Rivets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Garment Rivets Product Location Distribution
3.4.2 Players Garment Rivets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GARMENT RIVETS BY GEOGRAPHIC REGION
4.1 World Historic Garment Rivets Market Size by Geographic Region (2020-2025)
4.1.1 Global Garment Rivets Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Garment Rivets Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Garment Rivets Market Size by Country/Region (2020-2025)
4.2.1 Global Garment Rivets Annual Sales by Country/Region (2020-2025)
4.2.2 Global Garment Rivets Annual Revenue by Country/Region (2020-2025)
4.3 Americas Garment Rivets Sales Growth
4.4 APAC Garment Rivets Sales Growth
4.5 Europe Garment Rivets Sales Growth
4.6 Middle East & Africa Garment Rivets Sales Growth
5 AMERICAS
5.1 Americas Garment Rivets Sales by Country
5.1.1 Americas Garment Rivets Sales by Country (2020-2025)
5.1.2 Americas Garment Rivets Revenue by Country (2020-2025)
5.2 Americas Garment Rivets Sales by Type (2020-2025)
5.3 Americas Garment Rivets Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Garment Rivets Sales by Region
6.1.1 APAC Garment Rivets Sales by Region (2020-2025)
6.1.2 APAC Garment Rivets Revenue by Region (2020-2025)
6.2 APAC Garment Rivets Sales by Type (2020-2025)
6.3 APAC Garment Rivets Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Garment Rivets by Country
7.1.1 Europe Garment Rivets Sales by Country (2020-2025)
7.1.2 Europe Garment Rivets Revenue by Country (2020-2025)
7.2 Europe Garment Rivets Sales by Type (2020-2025)
7.3 Europe Garment Rivets Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Garment Rivets by Country
8.1.1 Middle East & Africa Garment Rivets Sales by Country (2020-2025)
8.1.2 Middle East & Africa Garment Rivets Revenue by Country (2020-2025)
8.2 Middle East & Africa Garment Rivets Sales by Type (2020-2025)
8.3 Middle East & Africa Garment Rivets Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Garment Rivets
10.3 Manufacturing Process Analysis of Garment Rivets
10.4 Industry Chain Structure of Garment Rivets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Garment Rivets Distributors
11.3 Garment Rivets Customer
12 WORLD FORECAST REVIEW FOR GARMENT RIVETS BY GEOGRAPHIC REGION
12.1 Global Garment Rivets Market Size Forecast by Region
12.1.1 Global Garment Rivets Forecast by Region (2026-2031)
12.1.2 Global Garment Rivets Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Garment Rivets Forecast by Type (2026-2031)
12.7 Global Garment Rivets Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Shun Shuay Enterprise
13.1.1 Shun Shuay Enterprise Company Information
13.1.2 Shun Shuay Enterprise Garment Rivets Product Portfolios and Specifications
13.1.3 Shun Shuay Enterprise Garment Rivets Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Shun Shuay Enterprise Main Business Overview
13.1.5 Shun Shuay Enterprise Latest Developments
13.2 Starling
13.2.1 Starling Company Information
13.2.2 Starling Garment Rivets Product Portfolios and Specifications
13.2.3 Starling Garment Rivets Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Starling Main Business Overview
13.2.5 Starling Latest Developments
13.3 Fitrite International
13.3.1 Fitrite International Company Information
13.3.2 Fitrite International Garment Rivets Product Portfolios and Specifications
13.3.3 Fitrite International Garment Rivets Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Fitrite International Main Business Overview
13.3.5 Fitrite International Latest Developments
13.4 Yiwu Xingmei Jewelry
13.4.1 Yiwu Xingmei Jewelry Company Information
13.4.2 Yiwu Xingmei Jewelry Garment Rivets Product Portfolios and Specifications
13.4.3 Yiwu Xingmei Jewelry Garment Rivets Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Yiwu Xingmei Jewelry Main Business Overview
13.4.5 Yiwu Xingmei Jewelry Latest Developments
13.5 Dongguan Yongfei Hardware Product
13.5.1 Dongguan Yongfei Hardware Product Company Information
13.5.2 Dongguan Yongfei Hardware Product Garment Rivets Product Portfolios and Specifications
13.5.3 Dongguan Yongfei Hardware Product Garment Rivets Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Dongguan Yongfei Hardware Product Main Business Overview
13.5.5 Dongguan Yongfei Hardware Product Latest Developments
13.6 Linyi Jinmei Metal Products
13.6.1 Linyi Jinmei Metal Products Company Information
13.6.2 Linyi Jinmei Metal Products Garment Rivets Product Portfolios and Specifications
13.6.3 Linyi Jinmei Metal Products Garment Rivets Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Linyi Jinmei Metal Products Main Business Overview
13.6.5 Linyi Jinmei Metal Products Latest Developments
13.7 Dongguan Jiacai Hardware
13.7.1 Dongguan Jiacai Hardware Company Information
13.7.2 Dongguan Jiacai Hardware Garment Rivets Product Portfolios and Specifications
13.7.3 Dongguan Jiacai Hardware Garment Rivets Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Dongguan Jiacai Hardware Main Business Overview
13.7.5 Dongguan Jiacai Hardware Latest Developments
13.8 Yiwu Oleeya Garment Accessories Factory
13.8.1 Yiwu Oleeya Garment Accessories Factory Company Information
13.8.2 Yiwu Oleeya Garment Accessories Factory Garment Rivets Product Portfolios and Specifications
13.8.3 Yiwu Oleeya Garment Accessories Factory Garment Rivets Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Yiwu Oleeya Garment Accessories Factory Main Business Overview
13.8.5 Yiwu Oleeya Garment Accessories Factory Latest Developments
13.9 Cixi Pat Fasteners
13.9.1 Cixi Pat Fasteners Company Information
13.9.2 Cixi Pat Fasteners Garment Rivets Product Portfolios and Specifications
13.9.3 Cixi Pat Fasteners Garment Rivets Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Cixi Pat Fasteners Main Business Overview
13.9.5 Cixi Pat Fasteners Latest Developments
13.10 Foshan Sailuk Rivet
13.10.1 Foshan Sailuk Rivet Company Information
13.10.2 Foshan Sailuk Rivet Garment Rivets Product Portfolios and Specifications
13.10.3 Foshan Sailuk Rivet Garment Rivets Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Foshan Sailuk Rivet Main Business Overview
13.10.5 Foshan Sailuk Rivet Latest Developments
13.11 Shenzhen Allcheers Electronic Technology
13.11.1 Shenzhen Allcheers Electronic Technology Company Information
13.11.2 Shenzhen Allcheers Electronic Technology Garment Rivets Product Portfolios and Specifications
13.11.3 Shenzhen Allcheers Electronic Technology Garment Rivets Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Shenzhen Allcheers Electronic Technology Main Business Overview
13.11.5 Shenzhen Allcheers Electronic Technology Latest Developments
13.12 Foshan Shunde Kamol Decorative Materials
13.12.1 Foshan Shunde Kamol Decorative Materials Company Information
13.12.2 Foshan Shunde Kamol Decorative Materials Garment Rivets Product Portfolios and Specifications
13.12.3 Foshan Shunde Kamol Decorative Materials Garment Rivets Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Foshan Shunde Kamol Decorative Materials Main Business Overview
13.12.5 Foshan Shunde Kamol Decorative Materials Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Proliferative Vitreoretinopathy (PVR) Therapeutics Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Proliferative Vitreoretinopathy (PVR) Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of PRM-167
Table 4. Major Players of XOMA-089
Table 5. Major Players of Others
Table 6. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Type (2020-2025) & (K Pcs)
Table 7. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Type (2020-2025)
Table 8. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue by Type (2020-2025) & ($ million)
Table 9. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Type (2020-2025)
Table 10. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sale Price by Type (2020-2025) & (USD/Pcs)
Table 11. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sale by Application (2020-2025) & (K Pcs)
Table 12. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sale Market Share by Application (2020-2025)
Table 13. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue by Application (2020-2025) & ($ million)
Table 14. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Application (2020-2025)
Table 15. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sale Price by Application (2020-2025) & (USD/Pcs)
Table 16. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Company (2020-2025) & (K Pcs)
Table 17. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Company (2020-2025)
Table 18. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Company (2020-2025)
Table 20. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sale Price by Company (2020-2025) & (USD/Pcs)
Table 21. Key Manufacturers Proliferative Vitreoretinopathy (PVR) Therapeutics Producing Area Distribution and Sales Area
Table 22. Players Proliferative Vitreoretinopathy (PVR) Therapeutics Products Offered
Table 23. Proliferative Vitreoretinopathy (PVR) Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Geographic Region (2020-2025) & (K Pcs)
Table 27. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share Geographic Region (2020-2025)
Table 28. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Country/Region (2020-2025) & (K Pcs)
Table 31. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Country/Region (2020-2025)
Table 32. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Country (2020-2025) & (K Pcs)
Table 35. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Country (2020-2025)
Table 36. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Type (2020-2025) & (K Pcs)
Table 38. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Application (2020-2025) & (K Pcs)
Table 39. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Region (2020-2025) & (K Pcs)
Table 40. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Region (2020-2025)
Table 41. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Type (2020-2025) & (K Pcs)
Table 43. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Application (2020-2025) & (K Pcs)
Table 44. Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Country (2020-2025) & (K Pcs)
Table 45. Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Type (2020-2025) & (K Pcs)
Table 47. Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Application (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Country (2020-2025) & (K Pcs)
Table 49. Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Type (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Application (2020-2025) & (K Pcs)
Table 52. Key Market Drivers & Growth Opportunities of Proliferative Vitreoretinopathy (PVR) Therapeutics
Table 53. Key Market Challenges & Risks of Proliferative Vitreoretinopathy (PVR) Therapeutics
Table 54. Key Industry Trends of Proliferative Vitreoretinopathy (PVR) Therapeutics
Table 55. Proliferative Vitreoretinopathy (PVR) Therapeutics Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Proliferative Vitreoretinopathy (PVR) Therapeutics Distributors List
Table 58. Proliferative Vitreoretinopathy (PVR) Therapeutics Customer List
Table 59. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Forecast by Region (2026-2031) & (K Pcs)
Table 60. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Forecast by Country (2026-2031) & (K Pcs)
Table 62. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Forecast by Region (2026-2031) & (K Pcs)
Table 64. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Forecast by Country (2026-2031) & (K Pcs)
Table 66. Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Forecast by Type (2026-2031) & (K Pcs)
Table 70. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Forecast by Application (2026-2031) & (K Pcs)
Table 72. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Novartis AG Basic Information, Proliferative Vitreoretinopathy (PVR) Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 74. Novartis AG Proliferative Vitreoretinopathy (PVR) Therapeutics Product Portfolios and Specifications
Table 75. Novartis AG Proliferative Vitreoretinopathy (PVR) Therapeutics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 76. Novartis AG Main Business
Table 77. Novartis AG Latest Developments
Table 78. Promedior Inc Basic Information, Proliferative Vitreoretinopathy (PVR) Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 79. Promedior Inc Proliferative Vitreoretinopathy (PVR) Therapeutics Product Portfolios and Specifications
Table 80. Promedior Inc Proliferative Vitreoretinopathy (PVR) Therapeutics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 81. Promedior Inc Main Business
Table 82. Promedior Inc Latest Developments
Table 83. RXi Pharmaceuticals Corp Basic Information, Proliferative Vitreoretinopathy (PVR) Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 84. RXi Pharmaceuticals Corp Proliferative Vitreoretinopathy (PVR) Therapeutics Product Portfolios and Specifications
Table 85. RXi Pharmaceuticals Corp Proliferative Vitreoretinopathy (PVR) Therapeutics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 86. RXi Pharmaceuticals Corp Main Business
Table 87. RXi Pharmaceuticals Corp Latest Developments
Table 1. Proliferative Vitreoretinopathy (PVR) Therapeutics Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Proliferative Vitreoretinopathy (PVR) Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of PRM-167
Table 4. Major Players of XOMA-089
Table 5. Major Players of Others
Table 6. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Type (2020-2025) & (K Pcs)
Table 7. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Type (2020-2025)
Table 8. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue by Type (2020-2025) & ($ million)
Table 9. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Type (2020-2025)
Table 10. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sale Price by Type (2020-2025) & (USD/Pcs)
Table 11. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sale by Application (2020-2025) & (K Pcs)
Table 12. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sale Market Share by Application (2020-2025)
Table 13. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue by Application (2020-2025) & ($ million)
Table 14. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Application (2020-2025)
Table 15. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sale Price by Application (2020-2025) & (USD/Pcs)
Table 16. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Company (2020-2025) & (K Pcs)
Table 17. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Company (2020-2025)
Table 18. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Company (2020-2025)
Table 20. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sale Price by Company (2020-2025) & (USD/Pcs)
Table 21. Key Manufacturers Proliferative Vitreoretinopathy (PVR) Therapeutics Producing Area Distribution and Sales Area
Table 22. Players Proliferative Vitreoretinopathy (PVR) Therapeutics Products Offered
Table 23. Proliferative Vitreoretinopathy (PVR) Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Geographic Region (2020-2025) & (K Pcs)
Table 27. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share Geographic Region (2020-2025)
Table 28. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Country/Region (2020-2025) & (K Pcs)
Table 31. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Country/Region (2020-2025)
Table 32. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Country (2020-2025) & (K Pcs)
Table 35. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Country (2020-2025)
Table 36. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Type (2020-2025) & (K Pcs)
Table 38. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Application (2020-2025) & (K Pcs)
Table 39. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Region (2020-2025) & (K Pcs)
Table 40. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Region (2020-2025)
Table 41. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Type (2020-2025) & (K Pcs)
Table 43. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Application (2020-2025) & (K Pcs)
Table 44. Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Country (2020-2025) & (K Pcs)
Table 45. Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Type (2020-2025) & (K Pcs)
Table 47. Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Application (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Country (2020-2025) & (K Pcs)
Table 49. Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Type (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Application (2020-2025) & (K Pcs)
Table 52. Key Market Drivers & Growth Opportunities of Proliferative Vitreoretinopathy (PVR) Therapeutics
Table 53. Key Market Challenges & Risks of Proliferative Vitreoretinopathy (PVR) Therapeutics
Table 54. Key Industry Trends of Proliferative Vitreoretinopathy (PVR) Therapeutics
Table 55. Proliferative Vitreoretinopathy (PVR) Therapeutics Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Proliferative Vitreoretinopathy (PVR) Therapeutics Distributors List
Table 58. Proliferative Vitreoretinopathy (PVR) Therapeutics Customer List
Table 59. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Forecast by Region (2026-2031) & (K Pcs)
Table 60. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Forecast by Country (2026-2031) & (K Pcs)
Table 62. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Forecast by Region (2026-2031) & (K Pcs)
Table 64. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Forecast by Country (2026-2031) & (K Pcs)
Table 66. Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Forecast by Type (2026-2031) & (K Pcs)
Table 70. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Forecast by Application (2026-2031) & (K Pcs)
Table 72. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Novartis AG Basic Information, Proliferative Vitreoretinopathy (PVR) Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 74. Novartis AG Proliferative Vitreoretinopathy (PVR) Therapeutics Product Portfolios and Specifications
Table 75. Novartis AG Proliferative Vitreoretinopathy (PVR) Therapeutics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 76. Novartis AG Main Business
Table 77. Novartis AG Latest Developments
Table 78. Promedior Inc Basic Information, Proliferative Vitreoretinopathy (PVR) Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 79. Promedior Inc Proliferative Vitreoretinopathy (PVR) Therapeutics Product Portfolios and Specifications
Table 80. Promedior Inc Proliferative Vitreoretinopathy (PVR) Therapeutics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 81. Promedior Inc Main Business
Table 82. Promedior Inc Latest Developments
Table 83. RXi Pharmaceuticals Corp Basic Information, Proliferative Vitreoretinopathy (PVR) Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 84. RXi Pharmaceuticals Corp Proliferative Vitreoretinopathy (PVR) Therapeutics Product Portfolios and Specifications
Table 85. RXi Pharmaceuticals Corp Proliferative Vitreoretinopathy (PVR) Therapeutics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 86. RXi Pharmaceuticals Corp Main Business
Table 87. RXi Pharmaceuticals Corp Latest Developments
LIST OF FIGURES
Figure 1. Picture of Proliferative Vitreoretinopathy (PVR) Therapeutics
Figure 2. Proliferative Vitreoretinopathy (PVR) Therapeutics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Country/Region (2024)
Figure 10. Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of PRM-167
Figure 12. Product Picture of XOMA-089
Figure 13. Product Picture of Others
Figure 14. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Type in 2025
Figure 15. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Type (2020-2025)
Figure 16. Proliferative Vitreoretinopathy (PVR) Therapeutics Consumed in Hospital
Figure 17. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market: Hospital (2020-2025) & (K Pcs)
Figure 18. Proliferative Vitreoretinopathy (PVR) Therapeutics Consumed in Clinic
Figure 19. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market: Clinic (2020-2025) & (K Pcs)
Figure 20. Proliferative Vitreoretinopathy (PVR) Therapeutics Consumed in ASCs
Figure 21. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market: ASCs (2020-2025) & (K Pcs)
Figure 22. Proliferative Vitreoretinopathy (PVR) Therapeutics Consumed in Others
Figure 23. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market: Others (2020-2025) & (K Pcs)
Figure 24. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sale Market Share by Application (2024)
Figure 25. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Application in 2025
Figure 26. Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Company in 2025 (K Pcs)
Figure 27. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Company in 2025
Figure 28. Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue by Company in 2025 ($ millions)
Figure 29. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Company in 2025
Figure 30. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Sales 2020-2025 (K Pcs)
Figure 33. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue 2020-2025 ($ millions)
Figure 34. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Sales 2020-2025 (K Pcs)
Figure 35. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue 2020-2025 ($ millions)
Figure 36. Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Sales 2020-2025 (K Pcs)
Figure 37. Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Sales 2020-2025 (K Pcs)
Figure 39. Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue 2020-2025 ($ millions)
Figure 40. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Country in 2025
Figure 41. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Country (2020-2025)
Figure 42. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Type (2020-2025)
Figure 43. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Application (2020-2025)
Figure 44. United States Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Region in 2025
Figure 49. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Region (2020-2025)
Figure 50. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Type (2020-2025)
Figure 51. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Application (2020-2025)
Figure 52. China Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 56. India Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Country in 2025
Figure 60. Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Country (2020-2025)
Figure 61. Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Type (2020-2025)
Figure 62. Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Application (2020-2025)
Figure 63. Germany Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 64. France Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Application (2020-2025)
Figure 71. Egypt Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Proliferative Vitreoretinopathy (PVR) Therapeutics in 2025
Figure 77. Manufacturing Process Analysis of Proliferative Vitreoretinopathy (PVR) Therapeutics
Figure 78. Industry Chain Structure of Proliferative Vitreoretinopathy (PVR) Therapeutics
Figure 79. Channels of Distribution
Figure 80. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Forecast by Region (2026-2031)
Figure 81. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Proliferative Vitreoretinopathy (PVR) Therapeutics
Figure 2. Proliferative Vitreoretinopathy (PVR) Therapeutics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Country/Region (2024)
Figure 10. Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of PRM-167
Figure 12. Product Picture of XOMA-089
Figure 13. Product Picture of Others
Figure 14. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Type in 2025
Figure 15. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Type (2020-2025)
Figure 16. Proliferative Vitreoretinopathy (PVR) Therapeutics Consumed in Hospital
Figure 17. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market: Hospital (2020-2025) & (K Pcs)
Figure 18. Proliferative Vitreoretinopathy (PVR) Therapeutics Consumed in Clinic
Figure 19. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market: Clinic (2020-2025) & (K Pcs)
Figure 20. Proliferative Vitreoretinopathy (PVR) Therapeutics Consumed in ASCs
Figure 21. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market: ASCs (2020-2025) & (K Pcs)
Figure 22. Proliferative Vitreoretinopathy (PVR) Therapeutics Consumed in Others
Figure 23. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market: Others (2020-2025) & (K Pcs)
Figure 24. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sale Market Share by Application (2024)
Figure 25. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Application in 2025
Figure 26. Proliferative Vitreoretinopathy (PVR) Therapeutics Sales by Company in 2025 (K Pcs)
Figure 27. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Company in 2025
Figure 28. Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue by Company in 2025 ($ millions)
Figure 29. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Company in 2025
Figure 30. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Sales 2020-2025 (K Pcs)
Figure 33. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue 2020-2025 ($ millions)
Figure 34. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Sales 2020-2025 (K Pcs)
Figure 35. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue 2020-2025 ($ millions)
Figure 36. Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Sales 2020-2025 (K Pcs)
Figure 37. Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Sales 2020-2025 (K Pcs)
Figure 39. Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue 2020-2025 ($ millions)
Figure 40. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Country in 2025
Figure 41. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Country (2020-2025)
Figure 42. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Type (2020-2025)
Figure 43. Americas Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Application (2020-2025)
Figure 44. United States Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Region in 2025
Figure 49. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Region (2020-2025)
Figure 50. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Type (2020-2025)
Figure 51. APAC Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Application (2020-2025)
Figure 52. China Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 56. India Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Country in 2025
Figure 60. Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share by Country (2020-2025)
Figure 61. Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Type (2020-2025)
Figure 62. Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Application (2020-2025)
Figure 63. Germany Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 64. France Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share by Application (2020-2025)
Figure 71. Egypt Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Proliferative Vitreoretinopathy (PVR) Therapeutics in 2025
Figure 77. Manufacturing Process Analysis of Proliferative Vitreoretinopathy (PVR) Therapeutics
Figure 78. Industry Chain Structure of Proliferative Vitreoretinopathy (PVR) Therapeutics
Figure 79. Channels of Distribution
Figure 80. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Forecast by Region (2026-2031)
Figure 81. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global Proliferative Vitreoretinopathy (PVR) Therapeutics Revenue Market Share Forecast by Application (2026-2031)
